The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10x Genomics Inc | CL A COM | 88025U109 | 93,588 | 660,933 | SH | SOLE | 1,2,3 | 660,933 | 0 | 0 | |
5 01 Acquisition Corp | COM CL A | 33836P105 | 3,987 | 392,000 | SH | SOLE | 1,2,3 | 392,000 | 0 | 0 | |
908 Devices Inc | COM | 65443P102 | 2,278 | 40,000 | SH | SOLE | 1,2,3 | 40,000 | 0 | 0 | |
Acutus Med Inc | COM | 005111109 | 13,017 | 451,834 | SH | SOLE | 1,2,3 | 451,834 | 0 | 0 | |
Adverum Biotechnologies Inc | COM | 00773U108 | 78,345 | 7,227,364 | SH | SOLE | 1,2,3 | 7,227,364 | 0 | 0 | |
Agenus Inc | COM NEW | 00847G705 | 40,910 | 12,864,677 | SH | SOLE | 1,2,3 | 12,864,677 | 0 | 0 | |
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 218,563 | 1,681,645 | SH | SOLE | 1,2,3 | 1,681,645 | 0 | 0 | |
Aptevo Therapeutics Inc | COM NEW | 03835L207 | 10,564 | 288,236 | SH | SOLE | 1,2,3 | 288,236 | 0 | 0 | |
Apyx Medical Corporation | COM | 03837C106 | 24,417 | 3,391,279 | SH | SOLE | 1,2,3 | 3,391,279 | 0 | 0 | |
Arbutus Biopharma Corp | COM | 03879J100 | 21,223 | 5,978,355 | SH | SOLE | 1,2,3 | 5,978,355 | 0 | 0 | |
argenx SE | SPONSORED ADR | 04016X101 | 9,338 | 31,752 | SH | SOLE | 1,2 | 31,752 | 0 | 0 | |
Arvinas Inc | COM | 04335A105 | 152,109 | 1,790,996 | SH | SOLE | 1,2,3 | 1,790,996 | 0 | 0 | |
Arya Sciences Acquisition Co | COM CL A | G3166W106 | 5,425 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 | |
Athira Pharma Inc | COM | 04746L104 | 88,899 | 2,685,779 | SH | SOLE | 1,2,3 | 2,685,779 | 0 | 0 | |
Avadel Pharmaceuticals plc | SPONSORED ADR | 05337M104 | 35,989 | 5,387,513 | SH | SOLE | 1,2,3 | 5,387,513 | 0 | 0 | |
Avidity Biosciences Inc | COM | 05370A108 | 101,952 | 3,995,000 | SH | SOLE | 1,2,3 | 3,995,000 | 0 | 0 | |
Axonics Modulation Technolog | COM | 05465P101 | 94,042 | 1,883,864 | SH | SOLE | 1,2,3 | 1,883,864 | 0 | 0 | |
Axsome Therapeutics Inc | COM | 05464T104 | 136,252 | 1,672,416 | SH | SOLE | 1,2,3 | 1,672,416 | 0 | 0 | |
Aziyo Biologics Inc | COM CL A | 05479K106 | 1,704 | 125,000 | SH | SOLE | 1,2,3 | 125,000 | 0 | 0 | |
Bcls Acquisition Corp | COM CL A | G0904B105 | 6,823 | 612,500 | SH | SOLE | 1,2,3 | 612,500 | 0 | 0 | |
BCTG Acquisition Corp | COM | 05492W103 | 6,864 | 600,000 | SH | SOLE | 1,2,3 | 600,000 | 0 | 0 | |
Bellus Health Inc New | COM NEW | 07987C204 | 15,778 | 5,189,862 | SH | SOLE | 1,2,3 | 5,189,862 | 0 | 0 | |
Berkeley Lts Inc | COM | 084310101 | 29,034 | 324,734 | SH | SOLE | 1,2,3 | 324,734 | 0 | 0 | |
Bioatla Inc | COM | 09077B104 | 340 | 10,000 | SH | SOLE | 1,2,3 | 10,000 | 0 | 0 | |
Biodesix Inc | COM | 09075X108 | 2,520 | 125,000 | SH | SOLE | 1,2,3 | 125,000 | 0 | 0 | |
BiomX Inc | *W EXP 10/16/202 | 09090D111 | 480 | 600,000 | SH | SOLE | 1,2 | 600,000 | 0 | 0 | |
Biomx Inc | COM | 09090D103 | 3,828 | 600,000 | SH | SOLE | 1,2 | 600,000 | 0 | 0 | |
Brainsway Ltd | SPONSORED ADS | 10501L106 | 8,320 | 1,103,474 | SH | SOLE | 1,2,3 | 1,103,474 | 0 | 0 | |
Burning Rock Biotech Ltd | SPONSORED ADS | 12233L107 | 693 | 30,000 | SH | SOLE | 1,2,3 | 30,000 | 0 | 0 | |
C4 Therapeutics Inc | COM STK | 12529R107 | 68,679 | 2,149,228 | SH | SOLE | 1,2,3 | 2,149,228 | 0 | 0 | |
Castle Biosciences Inc | COM | 14843C105 | 53,653 | 799,009 | SH | SOLE | 1,2,3 | 799,009 | 0 | 0 | |
Celldex Therapeutics Inc New | COM NEW | 15117B202 | 59,968 | 3,422,855 | SH | SOLE | 1,2,3 | 3,422,855 | 0 | 0 | |
Cerevel Therapeutics Hldng I | COM | 15678U128 | 8,290 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 | |
Cerevel Therapeutics Hldng I | *W EXP 06/09/202 | 15678U102 | 942 | 166,666 | SH | SOLE | 1,2,3 | 166,666 | 0 | 0 | |
Cerner Corp | COM | 156782104 | 133,548 | 1,701,680 | SH | SOLE | 1,2,3 | 1,701,680 | 0 | 0 | |
Chardan Healthcr Acqstn 2 Co | UNIT 99/99/9999 | 15957T206 | 3,707 | 350,000 | SH | SOLE | 1,2,3 | 350,000 | 0 | 0 | |
Clearside Biomedical Inc | COM | 185063104 | 10,845 | 3,958,130 | SH | SOLE | 1,2,3 | 3,958,130 | 0 | 0 | |
Curis Inc | COM NEW | 231269200 | 30,527 | 3,727,360 | SH | SOLE | 1,2,3 | 3,727,360 | 0 | 0 | |
Cytokinetics Inc | COM NEW | 23282W605 | 41,311 | 2,000,000 | SH | SOLE | 1,2,3 | 2,000,000 | 0 | 0 | |
Cytomx Therapeutics Inc | COM | 23284F105 | 10,004 | 1,527,352 | SH | SOLE | 1,2,3 | 1,527,352 | 0 | 0 | |
DermTech Inc | COM | 24984K105 | 93,661 | 2,887,215 | SH | SOLE | 1,2,3 | 2,887,215 | 0 | 0 | |
Dicerna Pharmaceuticals Inc | COM | 253031108 | 159,802 | 7,253,857 | SH | SOLE | 1,2,3 | 7,253,857 | 0 | 0 | |
Establishment Labs Hldgs Inc | COM | G31249108 | 87,292 | 2,319,138 | SH | SOLE | 1,2,3 | 2,319,138 | 0 | 0 | |
Exagen Inc | COM | 30068X103 | 16,502 | 1,250,131 | SH | SOLE | 1,2,3 | 1,250,131 | 0 | 0 | |
Five Prime Therapeutics Inc | COM | 33830X104 | 42,794 | 2,515,788 | SH | SOLE | 1,2,3 | 2,515,788 | 0 | 0 | |
Frequency Therapeutics Inc | COM | 35803L108 | 86,792 | 2,461,486 | SH | SOLE | 1,2,3 | 2,461,486 | 0 | 0 | |
Fulcrum Therapeutics Inc | COM | 359616109 | 24,256 | 2,071,409 | SH | SOLE | 1,2,3 | 2,071,409 | 0 | 0 | |
GenMark Diagnostics Inc | COM | 372309104 | 11,140 | 762,994 | SH | SOLE | 1,2,3 | 762,994 | 0 | 0 | |
Globus Med Inc | CL A | 379577208 | 107,017 | 1,640,859 | SH | SOLE | 1,2,3 | 1,640,859 | 0 | 0 | |
Guardant Health Inc | COM | 40131M109 | 75,004 | 581,970 | SH | SOLE | 1,2,3 | 581,970 | 0 | 0 | |
Helix Acquisition Corp | COM CL A | G4444C102 | 8,528 | 750,000 | SH | SOLE | 1,2,3 | 750,000 | 0 | 0 | |
Ideaya Biosciences Inc | COM | 45166A102 | 25,856 | 1,846,843 | SH | SOLE | 1,2,3 | 1,846,843 | 0 | 0 | |
Illumina Inc | COM | 452327109 | 133,858 | 361,778 | SH | SOLE | 1,2,3 | 361,778 | 0 | 0 | |
Immatics N.V | SHS | N44445109 | 3,777 | 350,000 | SH | SOLE | 1,2,3 | 350,000 | 0 | 0 | |
Immunic Inc | COM | 4525EP101 | 14,079 | 920,814 | SH | SOLE | 1,2,3 | 920,814 | 0 | 0 | |
Immunovant Inc | COM | 45258J102 | 350,686 | 7,592,253 | SH | SOLE | 1,2,3 | 7,592,253 | 0 | 0 | |
Inmode Ltd | SHS | M5425M103 | 5,935 | 124,999 | SH | SOLE | 1,2 | 124,999 | 0 | 0 | |
Itamar Med Ltd | SPONSORED ADS | 465437101 | 4,540 | 228,609 | SH | SOLE | 1,2,3 | 228,609 | 0 | 0 | |
Iteos Therapeutics Inc | COM | 46565G104 | 35,975 | 1,074,166 | SH | SOLE | 1,2,3 | 1,074,166 | 0 | 0 | |
IVERIC bio Inc | COM | 46583P102 | 46,453 | 6,722,624 | SH | SOLE | 1,2,3 | 6,722,624 | 0 | 0 | |
Johnson & Johnson | COM | 478160104 | 23,569 | 149,761 | SH | SOLE | 1,2,3 | 149,761 | 0 | 0 | |
Kura Oncology Inc | COM | 50127T109 | 55,580 | 1,701,781 | SH | SOLE | 1,2,3 | 1,701,781 | 0 | 0 | |
La Jolla Pharmaceutical Co | COM PAR $.0001 2 | 503459604 | 9,302 | 2,397,378 | SH | SOLE | 1,2,3 | 2,397,378 | 0 | 0 | |
Lifesci Acquisition Ii Corp | COM | 53229E103 | 6,936 | 650,000 | SH | SOLE | 1,2,3 | 650,000 | 0 | 0 | |
MacroGenics Inc | COM | 556099109 | 28,722 | 1,256,409 | SH | SOLE | 1,2,3 | 1,256,409 | 0 | 0 | |
Maravai Lifesciences Hldgs I | COM CL A | 56600D107 | 1,964 | 70,000 | SH | SOLE | 1,2,3 | 70,000 | 0 | 0 | |
Masimo Corp | COM | 574795100 | 125,982 | 469,416 | SH | SOLE | 1,2,3 | 469,416 | 0 | 0 | |
Milestone Pharmaceuticals In | COM | 59935V107 | 28,911 | 4,315,102 | SH | SOLE | 1,2,3 | 4,315,102 | 0 | 0 | |
MiMedx Group Inc | COM | 602496101 | 24,519 | 2,700,320 | SH | SOLE | 1,2,3 | 2,700,320 | 0 | 0 | |
Mirati Therapeutics Inc | COM | 60468T105 | 231,581 | 1,054,364 | SH | SOLE | 1,2,3 | 1,054,364 | 0 | 0 | |
NanoString Technologies Inc | COM | 63009R109 | 53,773 | 804,029 | SH | SOLE | 1,2,3 | 804,029 | 0 | 0 | |
Natera Inc | COM | 632307104 | 170,402 | 1,712,234 | SH | SOLE | 1,2,3 | 1,712,234 | 0 | 0 | |
Odonate Therapeutics Inc | COM | 676079106 | 19,203 | 1,000,139 | SH | SOLE | 1,2,3 | 1,000,139 | 0 | 0 | |
OraSure Technologies Inc | COM | 68554V108 | 1,948 | 184,000 | SH | SOLE | 1,2,3 | 184,000 | 0 | 0 | |
Outset Med Inc | COM | 690145107 | 33,256 | 585,074 | SH | SOLE | 1,2,3 | 585,074 | 0 | 0 | |
Oyster Pt Pharma Inc | COM | 69242L106 | 36,240 | 1,925,594 | SH | SOLE | 1,2,3 | 1,925,594 | 0 | 0 | |
Panacea Acquisition Corp | UNIT 99/99/9999 | 698102209 | 3,828 | 300,000 | SH | SOLE | 1,2,3 | 300,000 | 0 | 0 | |
Penumbra Inc | COM | 70975L107 | 20,698 | 118,273 | SH | SOLE | 1,2,3 | 118,273 | 0 | 0 | |
Personalis Inc | COM | 71535D106 | 4,668 | 127,501 | SH | SOLE | 1,2 | 127,501 | 0 | 0 | |
Pmv Pharmaceuticals Inc | COM | 69353Y103 | 30,809 | 500,882 | SH | SOLE | 1,2,3 | 500,882 | 0 | 0 | |
Profound Med Corp | COM NEW | 74319B502 | 2,510 | 122,098 | SH | SOLE | 1,2,3 | 122,098 | 0 | 0 | |
Progenity Inc | COM | 74319F107 | 531 | 100,000 | SH | SOLE | 1,2,3 | 100,000 | 0 | 0 | |
ProQR Thrapeutics N V | SHS EURO | N71542109 | 21,041 | 5,009,768 | SH | SOLE | 1,2,3 | 5,009,768 | 0 | 0 | |
Protagonist Therapeutics Inc | COM | 74366E102 | 73,585 | 3,650,069 | SH | SOLE | 1,2,3 | 3,650,069 | 0 | 0 | |
PTC Therapeutics Inc | COM | 69366J200 | 257,659 | 4,221,836 | SH | SOLE | 1,2,3 | 4,221,836 | 0 | 0 | |
Pulmonx Corp | COM | 745848101 | 74,839 | 1,129,600 | SH | SOLE | 1,2,3 | 1,129,600 | 0 | 0 | |
Regenxbio Inc | COM | 75901B107 | 12,803 | 282,260 | SH | SOLE | 1,2,3 | 282,260 | 0 | 0 | |
Relmada Therapeutics Inc | COM | 75955J402 | 48,511 | 1,512,673 | SH | SOLE | 1,2,3 | 1,512,673 | 0 | 0 | |
Rocket Pharmaceuticals Inc | COM | 77313F106 | 935,582 | 17,060,211 | SH | SOLE | 1,2,3,4 | 17,060,211 | 0 | 0 | |
Scholar Rock Hldg Corp | COM | 80706P103 | 8,065 | 166,183 | SH | SOLE | 1,2,3 | 166,183 | 0 | 0 | |
Seer Inc | COM CL A | 81578P106 | 225 | 4,000 | SH | SOLE | 1,2,3 | 4,000 | 0 | 0 | |
Stoke Therapeutics Inc | COM | 86150R107 | 219,495 | 3,544,248 | SH | SOLE | 1,2,3 | 3,544,248 | 0 | 0 | |
Tandem Diabetes Care Inc | COM NEW | 875372203 | 63,243 | 660,982 | SH | SOLE | 1,2,3 | 660,982 | 0 | 0 | |
Tarsus Pharmaceuticals Inc. | COM | 87650L103 | 98,987 | 2,463,601 | SH | SOLE | 1,2,3 | 2,463,601 | 0 | 0 | |
Tela Bio Inc | COM | 872381108 | 20,813 | 1,383,816 | SH | SOLE | 1,2,3 | 1,383,816 | 0 | 0 | |
Therapeutics Acquisition Cor | COM CL A | 88339T103 | 6,821 | 490,000 | SH | SOLE | 1,2,3 | 490,000 | 0 | 0 | |
Translate Bio Inc | COM | 89374L104 | 54,892 | 2,978,427 | SH | SOLE | 1,2,3 | 2,978,427 | 0 | 0 | |
Trillium Therapeutics Inc | COM NEW | 89620X506 | 31,850 | 2,165,197 | SH | SOLE | 1,2,3 | 2,165,197 | 0 | 0 | |
Twist Bioscience Corp | COM | 90184D100 | 2,610 | 18,473 | SH | SOLE | 1,2,3 | 18,473 | 0 | 0 | |
Vericel Corp | COM | 92346J108 | 139,503 | 4,517,570 | SH | SOLE | 1,2,3 | 4,517,570 | 0 | 0 | |
Vincera Pharma Inc | *W EXP 12/24/202 | 92731L114 | 1,650 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 | |
Vincera Pharma Inc | COM | 92731L106 | 10,455 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 |